Suggestions

Du même auteur

Gamma delta T cells in hepatocellular carcinoma: Sunrise of new therapy based on Vδ2 T cells?

Archive ouverte | Macek Jilkova, Zuzana | CCSD

International audience

Predictive Factors for Response to PD-1/PD-L1 Checkpoint Inhibition in the Field of Hepatocellular Carcinoma: Current Status and Challenges

Archive ouverte | Macek Jilkova, Zuzana | CCSD

International audience. Immunotherapies targeting immune checkpoints are fast-developing therapeutic approaches adopted for several tumor types that trigger unprecedented rates of durable clinical responses. Immune ...

Immunomodulation for hepatocellular carcinoma therapy: current challenges

Archive ouverte | Macek Jilkova, Zuzana | CCSD

International audience. Purpose of review The emergence of novel immunotherapies, such as immune-checkpoint inhibitors has changed the landscape of systemic cancer treatment. In hepatocellular carcinoma (HCC) patien...

Chargement des enrichissements...